BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10588823)

  • 21. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
    Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
    Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues.
    Lin JD; Chan EC; Chao TC; Chen KT; Hsueh C; Ho YS; Weng HF
    Ann Oncol; 2000 May; 11(5):625-9. PubMed ID: 10907960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of Na+/I- symporter distribution in human extra-thyroidal tissues.
    Vayre L; Sabourin JC; Caillou B; Ducreux M; Schlumberger M; Bidart JM
    Eur J Endocrinol; 1999 Oct; 141(4):382-6. PubMed ID: 10526253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.
    Muller I; Zhang L; Giani C; Dayan CM; Ludgate ME; Grennan-Jones F
    J Endocrinol Invest; 2016 Mar; 39(3):323-31. PubMed ID: 26253711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
    Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
    Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning of the human sodium lodide symporter.
    Smanik PA; Liu Q; Furminger TL; Ryu K; Xing S; Mazzaferri EL; Jhiang SM
    Biochem Biophys Res Commun; 1996 Sep; 226(2):339-45. PubMed ID: 8806637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium iodide symporter (NIS) gene expression in human placenta.
    Mitchell AM; Manley SW; Morris JC; Powell KA; Bergert ER; Mortimer RH
    Placenta; 2001; 22(2-3):256-8. PubMed ID: 11170832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
    Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
    Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease.
    Endo T; Kogai T; Nakazato M; Saito T; Kaneshige M; Onaya T
    Biochem Biophys Res Commun; 1996 Jul; 224(1):92-5. PubMed ID: 8694839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
    Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
    Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
    Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
    Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50.
    Venkataraman GM; Yatin M; Ain KB
    Thyroid; 1998 Jan; 8(1):63-9. PubMed ID: 9492156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
    Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
    Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
    Haberkorn U; Beuter P; Kübler W; Eskerski H; Eisenhut M; Kinscherf R; Zitzmann S; Strauss LG; Dimitrakopoulou-Strauss A; Altmann A
    J Nucl Med; 2004 May; 45(5):827-33. PubMed ID: 15136633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
    Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.